Aligos Therapeutics, Inc.
-
Ticker
ALGS
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in South San Francisco, California
Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of liver and viral diseases. Aligos’ strategy is to harness the deep expertise and decades of drug development experience its team has in liver and viral diseases to discover and develop potentially best in class therapeutics for nonalcoholic
…More steatohepatitis (NASH) and viruses with high unmet medical need such as coronaviruses and chronic hepatitis B (CHB).
REPORT RATINGS
3.8 / 5.0 (5)
Aligos Therapeutics, Inc. reports have an aggregate usefulness score of 3.8 based on 5 reviews.
Aligos Therapeutics, Inc.
Most Recent Annual Report
MOST RECENT
2023 Annual Report and Form 10K
Older/Archived Annual Reports